AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 806.00 Change Price %
High 815.00 1 Day 8.75 1.09
Low 803.00 1 Week 47.10 6.16
Close 812.00 1 Month 58.05 7.70
Volume 1875445 1 Year 159.85 24.51
52 Week High 891.50
52 Week Low 582.00
AUROPHARMA Important Levels
Resistance 2 823.12
Resistance 1 818.54
Pivot 810.00
Support 1 805.46
Support 2 800.88
NSE INDIA Most Active Stocks
UNITECH 4.55 -6.19%
ICICIBANK 214.45 -3.01%
VEDL 104.65 -4.86%
SUZLON 14.65 -2.33%
FEDERALBNK 48.85 4.16%
ADANIPORTS 208.25 -11.57%
ADANIPOWER 30.40 -3.95%
SBIN 179.95 -2.23%
JINDALSTEL 66.50 -3.55%
HDIL 79.75 -4.38%
More..
NSE INDIA Top Gainers Stocks
VISESHINFO 0.10 100.00%
PARASPETRO 0.20 33.33%
KSERASERA 0.25 25.00%
RASOYPR 0.25 25.00%
NAKODA 0.30 20.00%
HOVS 97.35 19.96%
RAJRAYON 0.45 12.50%
MICROSEC 80.10 11.33%
MOHITIND 43.85 10.59%
GTNIND 11.00 10.00%
More..
NSE INDIA Top Losers Stocks
ADHUNIK 10.30 -11.59%
ADANIPORTS 208.25 -11.57%
ICIL 948.45 -10.91%
PROVOGE 4.15 -10.75%
CEREBRAINT 16.55 -10.54%
SAMTEL 0.45 -10.00%
ATNINTER 0.45 -10.00%
BANG 16.95 -9.84%
BLKASHYAP 15.85 -9.69%
SIMPLEX 26.45 -9.42%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 4th May 2016 AUROPHARMA Share Price closed @ 812.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 758.05 & Strong Buy for SHORT-TERM with Stoploss of 721.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for May
1st Target up-side 801.37
2nd Target up-side 830.4
3rd Target up-side 859.43
1st Target down-side 718.53
2nd Target down-side 689.5
3rd Target down-side 660.47
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 67.29 Sideways
MFI (14) MFI is 63.04 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is 16.77 Range Bound
PSAR Stoploss For Long Buy 756.51
10 Day Avg Volume Traded 3.81 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.